American Oncology Network, Inc. Class A Common Stock
AONC
AONC was delisted on the 7th of June, 2024.
13 hedge funds and large institutions have $18.1M invested in American Oncology Network, Inc. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 69 closing their positions.
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
84% less funds holding
Funds holding: 79 → 13 (-66)
88% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 8
94% less capital invested
Capital invested by funds: $301M → $18.1M (-$283M)
96% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 69
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$1.48M |
| 2 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$981K |
| 3 |
MSU
Mizuho Securities USA
New York
|
+$273K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.05K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$15.5M |
| 2 |
Millennium Management
New York
|
-$15.3M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
-$15.2M |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$14.9M |
| 5 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$14.7M |
AONC Hedge Fund Activity: Q1 2023 in Review
13 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q1 2023, worth a combined $18.1M — down 94% from $301M a quarter earlier.
Sellers outnumbered buyers: 69 funds closed out of AONC and 3 opened new positions — a net loss of 66 holders — while 8 trimmed existing stakes and 1 added.
The largest buyer was UBS O'Connor, opening a new position worth an estimated $1.48M. The largest seller was Marshall Wace, exiting entirely with an estimated $15.5M sold.
- 13 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q1 2023, down from 79 in Q4 2022.
- Funds reported $18.1M of American Oncology Network, Inc. Class A Common Stock stock for Q1 2023, down 94% quarter-over-quarter.
- 3 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q1 2023 and 69 closed out, a net change of -66 holders.
- The largest American Oncology Network, Inc. Class A Common Stock buyer in Q1 2023 was UBS O'Connor, an estimated $1.48M added.
- The largest American Oncology Network, Inc. Class A Common Stock seller in Q1 2023 was Marshall Wace, an estimated $15.5M sold.
Based on aggregated 13F filings for Q1 2023.